Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Don’t Expect Much From Bank of America Corp (BAC) for a While

After finishing down more than 1.5% following a roller-coaster ride in the market yesterday, Bank of America Corp (NYSE:BAC) is down again this morning: 1.32% already in the first hour of trading. And with potentially tens of billions of dollars on the line in a reopened case involving — what else — soured mortgage-backed securities, don’t expect to see much of a rally today.

Bank of America Corp (NYSE:BAC)

That’s not fair

You probably know the story already, but just in case you don’t, here’s a quick recap: In June 2011, Bank of America Corp (NYSE:BAC) settled a suit brought by multiple investors — including BlackRock, Inc. (NYSE:BLK) and bond giant PIMCO — over soured mortgage-backed securities issued by Countrywide Financial, the subprime lending giant that Bank of America Corp (NYSE:BAC) acquired in 2008.

The agreed-upon amount was $8.5 billion, but some of the affected parties — including American International Group Inc (NYSE:AIG) — thought the settlement unfair. And now the case is back in court, with The Bank of New York Mellon Corporation Mellon (NYSE:BK) arguing in favor of the original amount, and BlackRock, Inc. (NYSE:BLK) and PIMCO in agreement with The Bank of New York Mellon Corporation Mellon (NYSE:BK).

Opponents of the settlement say losses due to the bad mortgage-backed securities could be as much as $100 billion. The presiding judge has set aside these first two weeks of June to hear the case.

The shadow knows

An $8.5 hit to the bottom line is bad enough, but it’s the potential for tens of billions more in damages that has investors spooked, and rightly so. The financial crisis is the gift that keeps on giving. Of all the banks that emerged alive from the crash, Bank of America Corp (NYSE:BAC) was unarguably in the worst shape and has consequentially had the longest road to recovery.

That said, the superbank is essentially solid at this point and in no danger of failing (especially given that it’s still too big to fail, with the implicit taxpayer guarantee that label comes with). But it’s the bottom-line-robbing suits like this one that spook investors and make the stock volatile. Do you ever see shares of Wells Fargo & Co (NYSE:WFC) spiking and plummeting the way Bank of America Corp (NYSE:BAC) shares do? No. Wells Fargo & Co (NYSE:WFC) is boring, but profitable, and it isn’t in court every other week for crisis-related drama.

Who knows what evil lurks in the heart of B of A’s balance sheet, and in the hearts of litigation-minded and crisis-scarred investors everywhere. B of A is a risky, potentially volatile investment to begin with: At the very least, don’t expect too much in the way of rallies out of the behemoth until this nail-biter of a two-week trial has ended.

The article Don’t Expect Much From Bank of America for a While originally appeared on and is written by John Grgurich.

Fool contributor John Grgurich owns no shares in any of the above-mentioned companies. Follow John’s dispatches from the not-so-muddy trenches of big-banking and high-finance on Twitter @TMFGrgurich. The Motley Fool recommends American International Group (NYSE:AIG), BlackRock, and Wells Fargo. The Motley Fool owns shares of American International Group, Bank of America, and Wells Fargo and (NYSE:WFC) has the following options: Long Jan 2014 $25 Calls on American International Group.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!